dr neal jain discusses type 2 inflammation in asthma
Published 4 years ago • 1.4K plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
4:14
dr neal jain discusses the use of dupilumab in oral steroid-dependent asthma
-
2:44
dr neal jain explains how dupilumab differentiated itself as a late-entrant to the asthma market
-
5:43
type 2 inflammation in asthma
-
2:54
dr neal jain on the real-world results of dupilumab in asthma
-
57:43
the role of type 2 inflammation in asthma, allergy and immunologic diseases
-
5:04
economic burden and type 2 inflammation
-
51:00
type 2 inflammation – severe asthma & co-morbidities
-
5:04
targeted pathology and associated biomarkers in asthma
-
2:29
neal jain, md: addressing inflammatory disease overlap with biologics
-
1:03:14
1/3/2020: eosinophil-related inflammation in asthma: clinical and therapeutics implications
-
11:29
what is type 2 inflammation? euforea innovation forum (part 1)
-
2:20
dr j. allen meadows outlines new long-term safety, efficacy data for dupilumab in asthma
-
54:19
11/08/2019: emerging endotypes and precision medicine in severe asthma
-
2:07
eosinophil-driven diseases (edds) / type 2 inflammation
-
39:19
finding the path to improved outcomes in uncontrolled persistent asthma
-
3:08
asthma: the types and treatments - dr. mark dykewicz
-
54:57
03/31/2020 translational targets for new asthma therapeutics
-
1:02:35
5/11/18: epigenomic therapies for inflammation-induced airway remodeling